MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Edwards Lifesciences Corporation Betriebsaufwand 2011-2025 | EW
Betriebsaufwand Jährlich Edwards Lifesciences Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.99 B | 1.71 B | 1.54 B | 1.38 B | 1.23 B | 1.21 B | 1.07 B | 997 M | 889 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.99 B | 889 M | 1.34 B |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
456 M | - | - | $ 17.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
560 M | $ 20.95 | -0.1 % | $ 2.99 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 9.28 | -0.32 % | $ 666 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.54 | 2.91 % | $ 123 M | USA |
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 95.79 | -0.24 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 303.53 | -0.15 % | $ 8.56 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 28.33 | -0.6 % | $ 240 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 48.37 | 0.74 % | $ 7.21 K | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 124.66 | -0.14 % | $ 217 B | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.25 | -4.41 % | $ 121 M |  France |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
136 M | $ 14.81 | 1.3 % | $ 1.17 B | Israel |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.17 | -4.88 % | $ 18.9 M | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 97.65 | 0.21 % | $ 1.24 B | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 62.29 | -0.93 % | $ 3.38 B |  Britain |
|
LENSAR
LNSR
|
32.6 M | $ 11.93 | -0.21 % | $ 137 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 158.32 | -0.03 % | $ 11.9 B | USA |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.81 | -1.31 % | $ 83.2 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.56 | -3.28 % | $ 366 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 14.46 | 0.07 % | $ 94.8 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 33.15 | 1.07 % | $ 1.47 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 41.41 | 1.57 % | $ 1.28 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
184 M | $ 17.7 | 2.08 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 88.34 | -0.08 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 12.58 | -0.32 % | $ 969 M | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |